BiotechTube
Home/Mesenkia Therapeutics/Carl-Henrik Heldin
CH

Carl-Henrik Heldin

Scientific Founder

Mesenkia Therapeutics

Therapeutic Areas

OncologyNeuro-oncology

Mesenkia Therapeutics Pipeline

DrugIndicationPhase
HV01GlioblastomaPre-clinical

Leadership Team at Mesenkia Therapeutics

MF
Moa Fransson
CEO
KM
Kohei Miyazono
Scientific Founder
BW
Bengt Westermark
Scientific Founder
CD
Cecilia Drakskog
Project Manager
LL
Liselotte Larsson
CMC Expert
View full Mesenkia Therapeutics profile